Details for New Drug Application (NDA): 090219
✉ Email this page to a colleague
NDA 090219 describes CLOTRIMAZOLE, which is a drug marketed by Fougera Pharms, Glenmark Pharms, Taro, P And L, Novitium Pharma, Sciegen Pharms Inc, Teva, Trupharma, Hikma, Padagis Us, Thinq Pharm-cro Pvt, Actavis Mid Atlantic, and Glenmark Speclt, and is included in nineteen NDAs. It is available from twenty-four suppliers. Additional details are available on the CLOTRIMAZOLE profile page.
The generic ingredient in CLOTRIMAZOLE is betamethasone dipropionate; clotrimazole. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; clotrimazole profile page.
The generic ingredient in CLOTRIMAZOLE is betamethasone dipropionate; clotrimazole. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; clotrimazole profile page.
Summary for 090219
| Tradename: | CLOTRIMAZOLE |
| Applicant: | Glenmark Pharms |
| Ingredient: | clotrimazole |
| Patents: | 0 |
Suppliers and Packaging for NDA: 090219
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLOTRIMAZOLE | clotrimazole | CREAM;TOPICAL | 090219 | ANDA | A-S Medication Solutions | 50090-7343 | 50090-7343-0 | 30 g in 1 TUBE (50090-7343-0) |
| CLOTRIMAZOLE | clotrimazole | CREAM;TOPICAL | 090219 | ANDA | Glenmark Pharmaceuticals Inc., USA | 68462-181 | 68462-181-17 | 15 g in 1 TUBE (68462-181-17) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 1% | ||||
| Approval Date: | Aug 3, 2010 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
